Nitric oxide scavenging, alone or with nitric oxide synthesis inhibition, modulates vascular hyporeactivity in rats with intraperitoneal sepsis

Shock

Volumn 17, Issue 5, 2002, Pages 423-426

  Kim, Hae W ^a,b   Greenburg, A Gerson ^a  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

Author keywords

Cecal ligation and puncture; Hemoglobin; L NAME; Peritonitis

Indexed keywords

BOVINE SERUM ALBUMIN; ENZYME INHIBITOR; HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; NOS2 PROTEIN, RAT; SCAVENGER;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; MALE; METABOLISM; PATHOPHYSIOLOGY; PERITONITIS; PHYSIOLOGY; RAT; SEPSIS; SPRAGUE DAWLEY RAT; VASCULAR RESISTANCE;

ANIMALS; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMODYNAMIC PROCESSES; HEMOGLOBINS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NOREPINEPHRINE; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SERUM ALBUMIN, BOVINE; VASCULAR RESISTANCE;

EID: 0036579770     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200205000-00014     Document Type: Article

References (33)

1. Battafarano RJ, Dunn DL: Role of nitric oxide during sepsis. Crit Care Med 20:1504-1505, 1992.
2. Kilbourn RG, Griffith OW: Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84:827-831, 1992.
3. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81, 1993.
4. Cobb JP, Danner RL: Nitric oxide and septic shock. J Am Med Assoc 275: 1992-1996, 1996.
5. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338:1555-1557, 1991.
6. Cobb JP, Natanson C, Hoffman WD, Lodato RF, Banks S, Koev CA, Solomon MA, Elin RJ, Hosseini JM, Danner RL: Nw-amino-L-arginine, an inhibitor of nitric oxide synthesis, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175-1182, 1992.
7. Cobb JP: Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red. Crit Care Med 27:855-856, 1999.
8. Hotchkiss RS, Karl IE, Parker JL, Adams HR: Inhibition of NO synthesis in septic shock. Lancet 339:434-435, 1992.
9. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264:H660-H663, 1993.
10. Tiao G, Rafferty J, Ogle C, Fischer JE, Hasseigren P: Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116:332-338, 1994.
11. Spain DA, Wilson MA, Bar-Natan MF, Garrison RN: Nitric oxide synthesis inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bactremia. J Trauma 36:720-725, 1994.
12. Brown IP, Williams RL, McKirman MD, Limjoco UR, Gray CG: Nitric oxide synthesis inhibition does not improve the hemodynamic responses to hemorrhagic shock in dehydrated conscious swine. Shock 3:292-298, 1995.
13. Booke MF, Hinder F, McGuire R, Traber LD, Traber DL: Selecitve inhibition of inducible nitric oxide synthase: effects of hemodynamics and regional blood flow in healthy and septic sheep. Crit Care Med 27:162-157, 1999.
14. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
15. Gibson QH, Roughton FJW: The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 136:507-526, 1957.
16. Kim HW, Hughes JK, Breiding P, Greenburg AG: Nitric oxide scavenging: an alternative therapeutic approach to nitric oxide synthesis inhibition in nitric oxide-mediated hypotension of sepsis. Surg Forum 45:67-69, 1994.
17. Greenburg AG, Kim HW: Nitrosyl hemoglobin formation in vivo after intravenous administration of a hemoglobin-based oxygen carrier in endotoxemic rats. Art Cells Blood Subs Immob Biotechnol 23:271-276, 1995.
18. Wichterman KA, Baue A, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
19. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxic shock. Cardiovasc Res 26:48-57, 1992.
20. Grover R, Lopez A, Lorente J, et al.: Multi-center, randomized, placebo controlled, double blind study of nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 27(Suppl 1):A33, 1999.
21. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
22. Scott JA, Machoun M, McCormack DG: Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. Am J Phvsiol 80:271-277, 1996.
23. Karupiah G, Xie Q, Buller RML, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science 261:1445-1448, 1993.
24. Cobb JP, Hotchikiss RS, Swanson PE, Chang K, Qiu Y, Laubach VE, Karl IE, Buchman TG: Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 125:438-442, 1999.
25. Murray HW, Nathan CF: Macrophage microbial mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189:741-746, 1999.
26. Bone HG, Fischer SR, Schenarts PJ, McGuire R, Traber LD, Traber DL: Continuous infusion of pyridoxalated hemoglobin polyoxyethylene conjugate in hyperdynamic septic sheep. Shock 10:69-76, 1998.
27. Heneka MT, Loschmann PA, Osswald H: Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat. J Clin Invest 99:47-54, 1997.
28. Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 25:1480-1488, 1997.
29. Shieh P, Zhou M, Oman DA, Chaudry IH, Wang P: Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis. Shock 12:325-329, 2000.
30. Morin MJ, Unno N, Hodin RA, Fink MP: Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 26:1258-1264, 1998.
31. Cook HT, Bune AJ, Jansen AS, et al.: Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci 87:179-186, 1994.
32. Chen K, Inoue M, Okada A: Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem Biophys Res Commun 224:703-708, 1996.
33. Fujii H, Koscielniak J, Berliner LJ: Determination and characterization of nitric oxide generation in mice by in vivo L-band EPR spectroscopy. Magn Reson Med 38:565-568, 1997.